Cardiometabolic determinants of mortality in a geriatric population: Is there a "reverse metabolic syndrome"?

Diabetes and Metabolism

Volumn 35, Issue 2, 2009, Pages 108-114

  Vischer, U M ^a   Safar, M E ^b   Safar, H ^b   Iaria, P ^b   Le Dudal, K ^b   Henry, O ^b   Herrmann, F R ^a   Ducimetiere P ^c   Blacher, J ^b,c  

^a Hopital de Geriatrie   (Switzerland)

^b HÔTEL DIEU   (France)

^c INSERM   (France)

Author keywords

Ageing; Dyslipidaemia; Hypertension; Insulin resistance; Mortality; Predictive factors

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; FEMALE; GERIATRIC PATIENT; HEART INFARCTION; HUMAN; INSULIN SENSITIVITY; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; METABOLIC SYNDROME X; MORTALITY; PREDICTOR VARIABLE;

AGED; AGED, 80 AND OVER; AGING; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COHORT STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; KAPLAN-MEIERS ESTIMATE; MALE; MALNUTRITION; MORTALITY; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 64549085344     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2008.08.006     Document Type: Article

References (37)

1. Lakatta E.G., and Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a "set up" for vascular disease. Circulation 107 (2003) 139-146
2. Wang J., Ruotsalainen S., Moilanen L., Lepisto P., Laakso M., and Kuusisto J. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns. Eur Heart J 28 (2007) 857-864
3. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
4. Alberti K.G., Zimmet P., and Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 366 (2005) 1059-1062
5. Staessen J.A., Fagard R., Thijs L., Celis H., Birkenhager W.H., Bulpitt C.J., et al. Subgroup and per-protocol analysis of the randomized European trial on isolated systolic hypertension in the elderly. Arch Intern Med 158 (1998) 1681-1691
6. Gueyffier F., Bulpitt C., Boissel J.P., Schron E., Ekbom T., Fagard R., et al. Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials, INDANA Group. Lancet 353 (1999) 793-796
7. Satish S., Zhang D.D., and Goodwin J.S. Clinical significance of falling blood pressure among older adults. J Clin Epidemiol 54 (2001) 961-967
8. Boshuizen H.C., Izaks G.J., van Buuren S., and Ligthart G.J. Blood pressure and mortality in elderly people aged 85 and older: community based study. BMJ 316 (1998) 1780-1784
9. Iso H., Jacobs D.R., Wentworth D., Neaton J.D., and Cohen J.D. Serum cholesterol levels and six-year mortality from stroke in 350 977 men screened for the multiple risk factor intervention trial. N Engl J Med 320 (1989) 904-910
10. Casiglia E., Mazza A., Tikhonoff V., Scarpa R., Schiavon L., and Pessina A.C. Total cholesterol and mortality in the elderly. J Intern Med 254 (2003) 353-362
11. Tikhonoff V., Casiglia E., Mazza A., Scarpa R., Thijs L., Pessina A.C., et al. Low-density lipoprotein cholesterol and mortality in older people. J Am Geriatr Soc 53 (2005) 2159-2164
12. Schatz I.J., Masaki K., Yano K., Chen R., Rodriguez B.L., and Curb J.D. Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study. Lancet 358 (2001) 351-355
13. Weverling-Rijnsburger A.W., Jonkers I.J., van Exel E., Gussekloo J., and Westendorp R.G. High-density versus low-density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age. Arch Intern Med 163 (2003) 1549-1554
14. Volpato S., Leveille S.G., Corti M.C., Harris T.B., and Guralnik J.M. The value of serum albumin and high-density lipoprotein cholesterol in defining mortality risk in older persons with low serum cholesterol. J Am Geriatr Soc 49 (2001) 1142-1147
15. Monarque-Favard C., Garcia I., Abidi H., Bannier E., Riviere J., Drai J., et al. Malnourished elderly people and lipid status. J Nutr Health Aging 6 (2002) 370-374
16. Volpato S., Palmieri E., Fellin R., and Zuliani G. Acute phase markers are associated with reduced plasma lipid levels in a population of hospitalized elderly patients. Gerontology 46 (2000) 22-27
17. Nawaz H., Comerford B.P., Njike V.Y., Dhond A.J., Plavec M., and Katz D.L. Repeated serum lipid measurements during the peri-hospitalization period. Am J Cardiol 98 (2006) 1379-1382
18. Mazzali G., Di Francesco V., Zoico E., Fantin F., Zamboni G., Benati C., et al. Interrelations between fat distribution, muscle lipid content, adipocytokines, and insulin resistance: effect of moderate weight loss in older women. Am J Clin Nutr 84 (2006) 1193-1199
19. Kalmijn S., Curb J.D., Rodriguez B.L., Yano K., and Abbott R.D. The association of body weight and anthropometry with mortality in elderly men: the Honolulu Heart Program. Int J Obes 23 (1999) 395-402
20. Stevens J., Cai J., Pamuk E.R., Williamson D.F., Thun M.J., and Wood J.L. The effect of age on the association between body mass index and mortality. N Engl J Med 338 (1998) 1-7
21. Pyorala M., Miettinen H., Laakso M., and Pyorala K. Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: the 22-Year follow-up results of the Helsinki policemen study. Circulation 98 (1998) 398-404
22. Bonin-Guillaume S., Herrmann F.R., Boillat D., Szanto I., Michel J.P., Rohner-Jeanrenaud F., et al. Insulinemia and leptinemia in geriatric patients: markers of the metabolic syndrome or of undernutrition?. Diabetes Metab 32 (2006) 236-243
23. Hajjar I., and Kotchen T.A. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 290 (2003) 199-206
24. Blacher J., Iaria P., Safar H., Le Dudal K., Fontbonne A., Henry O., et al. Structure and function of the arteries of very elderly people. The PROTEGER Study (cardiovascular prognosis and therapeutic optimization in geriatrics). J Mal Vasc 27 (2002) S24-S29
25. Protogerou A.D., Safar M.E., Iaria P., Safar H., Le Dudal K., Filipovsky J., et al. Diastolic blood pressure and mortality in the elderly with cardiovascular disease. Hypertension 50 (2007) 172-180
26. Chumlea W.C., Guo S.S., Wholihan K., Cockram D., Kuczmarski R.J., and Johnson C.L. Stature prediction equations for elderly non-Hispanic white, non-Hispanic black, and Mexican-American persons developed from NHANES III data. J Am Diet Assoc 98 (1998) 137-142
27. Gallois Y, Vol S, Caces E, Balkau B. Distribution of fasting serum insulin measured by enzyme immunoassay in an unselected population of 4032 individuals. Reference values according to age and sex. DESIR Study Group. Donnees épidemiologiques sur le syndrome d'insulino-resistance. Diabetes Metab 1996; 22:427-31.
28. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
29. Katz A., Nambi S.S., Mather K., Baron A.D., Follmann D.A., Sullivan G., et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85 (2000) 2402-2410
30. Weyer C., Bogardus C., Mott D.M., and Pratley R.E. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104 (1999) 787-794
31. Katsuki A., Sumida Y., Urakawa H., Gabazza E.C., Murashima S., Morioka K., et al. Neither homeostasis model assessment nor quantitative insulin sensitivity check index can predict insulin resistance in elderly patients with poorly controlled type 2 diabetes mellitus. J Clin Endocrinol Metab 87 (2002) 5332-5335
32. Elia M. Obesity in the elderly. Obesity Res 9 (2001) 244S-248S
33. Bigaard J., Frederiksen K., Tjonneland A., Thomsen B.L., Overvad K., Heitmann B.L., et al. Body fat and fat-Free mass and all-cause mortality. Obesity Res 12 (2004) 1042-1049
34. Janssen I., Katzmarzyk P.T., and Ross R. Body mass index is inversely related to mortality in older people after adjustment for waist circumference. J Am Geriatr Soc 53 (2005) 2112-2118
35. Packard C.J., Ford I., Robertson M., Shepherd J., Blauw G.J., Murphy M.B., et al. Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER). Circulation 112 (2005) 3058-3065
36. Scuteri A., Najjar S.S., Morrell C.H., and Lakatta E.G. The metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events: the Cardiovascular Health Study. Diabetes Care 28 (2005) 882-887
37. Ravaglia G., Forti P., Maioli F., Bastagli L., Chiappelli M., Montesi F., et al. Metabolic syndrome: prevalence and prediction of mortality in elderly individuals. Diabetes Care 29 (2006) 2471-2476